Showing posts with label treatment program. Show all posts
Showing posts with label treatment program. Show all posts

Tuesday, April 25, 2017

treatment programs

hi my name is dr. kim makoi. i'm a holisticchiropractor and certified addictionologist in san francisco, california and this is howto find an inpatient alcohol treatment program. in searching for an inpatient alcohol treatmentprogram it is very important to look for a facility that has a well established treatmentprogram and that is taking an integrative approach to treating the addiction. all addictionsare multi faceted and it is not just about the actual chemical detox from the alcoholbut it is important that the person also receives support from the psychiatric angle, make surethat they are addressing the stress components. it is important that the whole family is involvedin the process because every addict has an enabler and a codependent so there are manythings to look into. in recent times the nutritional
aspects of addiction are also coming moreinto play and so an integrative approach will help the patient to take a look at and tacklenot just the drinking itself but also the environmental factors by it and all of thefactors involved and those will lead to a much better outcome. so those are the thingsto look for when looking for an inpatient alcohol treatment program.

treatment of alcoholism

researchers say there are several medicationsthat can help alcoholics quit their drinking. thing is, they're rarely prescribed. according to the national institutes of health,about 18 million americans suffer from alcohol use disorders. auds are "medical conditionsthat doctors can diagnose when a patient's drinking causes distress or harm. ... classifiedas either alcohol dependence—perhaps better known as alcoholism—or alcohol abuse." (flickr/ pmorgan, kirti poddar​) researchers led by daniel jonas of the universityof north carolina at chapel hill reviewed and analyzed over 100 clinical trials testingthe two drugs. (via flickr / nvinacco) ​the group presented its results using ameasure called "number needed to treat," or
nnt, which measures the average number ofpatients treated before one benefits. according to the press release, acamprosate's nnt was12, and oral naltrexone's was 20. (via journal of the american medical association) for comparison, widely used cholesterol druglipitor has an nnt of 100, according to this report by businessweek. the study's lead researcher tells bloombergless than 10 percent of patients with auds get medication for them. he says that's due,in part, to doubt surrounding the effectiveness of the drugs. "historically, that's because of the uncertaintyover whether they work. people with alcohol
use disorders have serious problems. theyneed help and they are often not getting help. one piece of the treatment is these medicines."(via bloomberg) the study found that a commonly used drugin alcohol abuse prevention — disulfiram — did not appear to help patients with alcoholuse disorders. according to the u.s. national library ofmedicine, disulfiram affects the way the body breaks down alcohol, causing uncomfortablesymptoms like nausea, headache and chest pain. acamprosate and naltrexone work much differently.acamprosate appears to return the brain to normal functioning after it has been alteredby alcohol abuse, and naltrexone decreases the craving for alcohol.
the group hopes the research will help thosesuffering from auds gain access to helpful medications. "by identifying 4 effective medicationsfor aud ... the authors highlight treatment options for a common medical condition forwhich patient-centered care is not currently the norm." (via medical daily)

treatment for cocaine addiction

bom dia, buenos dias, good morning ok, what i'd like to do today is to share our work and effort in brazil to advance ibogaine therapy for drug addiction in our case, the problem there is not opiates but cocaine and crack cocaine we've been working in this for some 3 or 4 years and we are now prety much ready
to start a very good, rigorous clinical trial which i'll talk in the end so i put the title as regulating a treatment with ibogaine so there are two important things why i put this title one is that ibogaine is not a treatment by itself ok? so everything i'm going to show
happened with psychotherapy before and psychotherapy after, right? and second, it is our goal to have a treatment regulated and recognized by the government so it can be accessible to more people so when we're talking about ibogaine i think it's important to pay some tribute to those that began this
howard lotsof, it was an honor to listen to his wife norma yesterday and if you go to consider the peer-reviewed scientific literature until 2006 there was this paper claiming that 3400 people have undergone ibogaine treatment people here in this conference talk about a much larger number
but before i proceed i think it's important for us to consider the differences very important differences between ibogaine and iboga we can never, from the pharmacological point of view should never confuse a molecule, a substance with its plant source, right?
the plant, we saw yesterday the iboga plant contain many other alkaloids that may have different effects there are different types of iboga plant from what we learned yesterday at least seven different types of plants and i think we should make an effort to be more precise using the words so if you're working with the plants
or with total alkaloid extracts and things like that you should not say you're doing ibogaine treatment because it creates and perpetuates confusion ok? and this has to do with the safety thing that was also spoken yesterday but furthermore
when we're talking about plants we're talking about a live organism we're talking about culture we're talking about ritual and lots of other things that appeared yesterday and when we are talking about molecules it tend to be the phd guys in white coats but i don't necessarily see these things as being in tension,
or disrespect to each other i think that biotechnology can work cooperatively with the sustainability and with respect to the traditions at least this is the approach we try to do with plantando consciencia so when we're talking about iboga and ibogaine we have this safety issue
that needs to be further investigated in our case, the clinical trial we'll also do this which mainly relates to arrhythmias cardiac arrhythmias that can be fatal probably because of prolongation of the qt interval in the electrocardiogram so this is very very important
to be studied in depth and we want to do this soon and it is probably related it's the best explanation in medicine so far for the unfortunate fatalities that are recorded in the literature so according to the best paper in this a review by professor alper
who is here in the conference a 2012 paper they cataloged 19 fatalities which they called, wisely called "temporally related fatalities to ibogaine" so these cases happened between 1.5 to 72 hours after taking the ibogaine so some of them were not acute since the publication of this paper
we have at least 2 more cases in the peer-reviewed literature one of them involving a patient with methadone which the post-mortem data revealed that the patient had high doses of methadone and benzodiazepine when he took the ibogaine so that might be a helpful explanation for this fatality
if we divide this by the 3400 cases we get approximately 0.6% less than 1% of the ibogaine treatments resulting in fatalities this is probably lower because as i said, many more treatments are happening that are not recorded in the peer reviewed literature regarding the medical potential we just heard the experts here
ibogaine is much more known very well known treatment to reduce opioid cravings and to help patients in heroine or methadone what we published in 2014 i hope you know the paper i'll just describe a brief resume it's published in the journal of psychopharmacology we did a retrospective study
i interviewed 75 drug abusers and drug dependent patients they used alcohol, cigarettes i don't like saying tobacco tobacco is a different thing is a plant, it has all the other issues it is a sacred plant by itself cannabis or marijuana or maconha or whatever you wanna call it
and cocaine or crack so around 70% of our sample we can call them polydrug users they used many of these drugs but for most of them the real problem in their life was crack and cocaine these patients started very soon the average age of onset
was ten years old for alcohol eleven years old for cigarettes 13 years old for cannabis and around 15 for cocaine if we go for the minimun there was a patient that started drinking alcohol as early as seven years old they had many many attempts to treat themselves in many different treatment modalities
for drug addiction the median was four previous attempts of treatment so this people were not like easy, like people trying drugs and trying this outlandish thing this ibogaine thing these were people with heavy suffering that the medical system could not help
and then they decided for some alternative and what we found was for eight women in the sample they were all found abstinent when we contacted them and from 67 men we found 72% of them abstinent at the time of contact so we could say the treament
was effective for 70% of the men and 100% of the women although the number of women is pretty low however some ten or eleven of the men that were abstinent when i interviewed them they were doing other treatments if you wanna be conservative and say well, if he's doing another treatment the ibogaine treatment failed
then we go for 57% success in men these numbers are extraordinarily high in the treatment of addiction specially to psychostimulants like cocaine and crack for which there is no pharmacological treatment whatsoever that medicine can offer these people so this is the first thing
and it seems to be working even more important we had no records of cardiac arrhythmias no fatalities no serious adverse event in the whole study now we have just discussed in the previous section abstinence is not everything first of all we need to see
how long were they abstinent so some of these patients most of them, took ibogaine only once some took ibogaine twice and very few took it three times and very very few more than three if we analyze after the first ibogaine session we found that people stayed abstinent for five and a half months
clinical trials for psychostimulants are celebrating results in weeks abstinent of cocaine when they get three weeks without the use of cocaine they publish a paper we're talking here about 5.5 months if we look to the data including all ibogaine sessions
this increases to 8.4 months abstinent with this treatment pretty incredible very very awesome stuff this was published in 2014 but it is not our view that abstinence is the whole story in drug dependence we really think that we need to listen to these people
we need to understand their stories to understand why they were like they were, in this situation and why did they improve so we conducted a qualitative research interviewing 21 of those for a longer time and this is the type of things they say i saw my father dying my mother crying
i saw my wedding my father hand in hand with me very beautiful i remembered my baby blanket my brother being spanked by my father then i understood him - the brother i had this very bad thing inside of me - this is a woman, i really like this quotation
and only with ibogaine i could free from it a little sad girl that lived inside of me i saw this little girl growing until it stuck to me it was myself, growing and maturing ibogaine made it crystal clear that i would die if i kept taking drugs and doing things like i was doing
i saw my deceased relatives who also had drug problems - so the patient starts realizing it is not about himself only there is a heritage transmission of behavior and suffering, trauma, intergenerational trauma it was very spiritual, i still have much to work on
- very important as well it's not like end of story you're cured, go home there is much to work on but that's what was missing i wasn't noticing the spiritual side of my life at the beggining i thought it wouldn't hit me, you know? but then it made its effect wow, i found myself you know?
for the first time in my life i saw myself without a mirror i saw myself and i kissed and i hugged myself - loving oneself, very very important for about one year and a half we're trying to publish these studies we have two papers submitted but they over and over again
they reject our studies without peer-review the editors just say no, this is not important this is not interesting this is not scientific there is no statistics in there we don't have much to learn and it will not help the community
to know the stories of the patients that used ibogaine very sad situation anyway, we used a paper in the prestigious journal addiction which defines secondary outcomes that could be used to assess drug dependence treatments beyond abstinence
and these include cravings, quality of life, psychosocial functioning family support social support and self-efficacy when we go to the qualitative reports we find that, for the group of course not for every single patient
but for the group they improved in all these domains so this shows us that there is much more that can be done with ibogaine treatments beyond maintaining people far from drug use so then there comes this question
can an ibogaine treatment be a medical solution for the crack issue? that in brazil is considered a public health emergency? for you to have an idea the federal government planned to spend in 2013 12 billion reais you divide this by 4
and you have this in dollars like 3 billion dollars in actions education and programs and therapies that we know that don't work to try to solve this thing and then we sent them our clinical trial asking for money and they ignored us they don't even reply
it's a very complicated situation anyway, we are keeping strong in this we have a good team there are some brazilians here helping me out we are going to find the way to do this we will find the necessary resources and we already have
our clinical trial protocol double blind, randomized, placebo controlled to use ibogaine hydrochloryde with previous psychotherapy post-session integrative psychotherapy and all standardized measures so we have published and standard psychiatric rating scales
to assess abstinence, cravings quality of life all those measures we have the psychedelic questionnaires like the hallucinogen rating scale the states of consciousness questionnaire to look more in depth to what happens during the ibogaine and to try to correlate that over time
we have a cardiologist onboard we are going to do 24 hour cardiac monitoring we're gonna study what happens with the qt interval if there is any arrhythmia how it relates to the baseline of each patient we're gonna periodically collect blood samples so we can quantify ibogaine and noribogaine in the plasma
we can do a time curve and we can relate these to ecg and to the therapeutic effects this is how i see we can move a little bit in the direction of causality so if we have any arrhythmia we'll have the plasma data to look at to see if it correlates with ibogaine or noribogaine
rising up in the blood, in the system so i'm really happy and glad we're making these advances i'm firmly convinced we can get the funds this year and we can start this hopefully next semester we can quite easily import ibogaine from phytostan in canada
the whole work bruno [rasmussen chaves] will present tomorrow from this retrospective study was done from ibogaine hcl from phytostan we can get it for the clinical trial there is not much bureaucracy involved from our part and the protocol is already submitted
to an ethical review board it's ongoing we should get approval in around two months and you can contribute to this and please do! ok? we can cooperate in many ways we're starting also an mdma pilot phase 2 study for ptsd
for which we did a crowdfunding in brazil and raised like 50 thousand reais which is about 12 thousand dollars in a month and i believe if we could organize we can raise funds for ibogaine research and this would be one of the beautiful consequences of a conference like this
we are also negotiating in other forms we have this, we have this small flyers like this, over there next to that banner please take more than one take it with you, distribute it around help us to reach more people, so we can make this happen
and hopefully bring ibogaine therapy to the next level which i think is the dream of many present here today thank you

treatment for alcoholism

researchers say there are several medicationsthat can help alcoholics quit their drinking. thing is, they're rarely prescribed. according to the national institutes of health,about 18 million americans suffer from alcohol use disorders. auds are "medical conditionsthat doctors can diagnose when a patient's drinking causes distress or harm. ... classifiedas either alcohol dependence—perhaps better known as alcoholism—or alcohol abuse." (flickr/ pmorgan, kirti poddar​) researchers led by daniel jonas of the universityof north carolina at chapel hill reviewed and analyzed over 100 clinical trials testingthe two drugs. (via flickr / nvinacco) ​the group presented its results using ameasure called "number needed to treat," or
nnt, which measures the average number ofpatients treated before one benefits. according to the press release, acamprosate's nnt was12, and oral naltrexone's was 20. (via journal of the american medical association) for comparison, widely used cholesterol druglipitor has an nnt of 100, according to this report by businessweek. the study's lead researcher tells bloombergless than 10 percent of patients with auds get medication for them. he says that's due,in part, to doubt surrounding the effectiveness of the drugs. "historically, that's because of the uncertaintyover whether they work. people with alcohol
use disorders have serious problems. theyneed help and they are often not getting help. one piece of the treatment is these medicines."(via bloomberg) the study found that a commonly used drugin alcohol abuse prevention — disulfiram — did not appear to help patients with alcoholuse disorders. according to the u.s. national library ofmedicine, disulfiram affects the way the body breaks down alcohol, causing uncomfortablesymptoms like nausea, headache and chest pain. acamprosate and naltrexone work much differently.acamprosate appears to return the brain to normal functioning after it has been alteredby alcohol abuse, and naltrexone decreases the craving for alcohol.
the group hopes the research will help thosesuffering from auds gain access to helpful medications. "by identifying 4 effective medicationsfor aud ... the authors highlight treatment options for a common medical condition forwhich patient-centered care is not currently the norm." (via medical daily)

Monday, April 24, 2017

treating alcoholism

treating alcoholism

there's no one-size-fits-allapproach to achieving a sustained recovery from addictioneveryone develops their addiction for unique biological psychological and social reasons. theharm that addiction causes is specific to each individual too. successful treatment incorporates multiple components targeting particular aspects of theillness and its consequences the first step is abstinence. forsubstance abusers this may involve

medically supervised detoxification to relieve the sometimeslife-threatening physical effects of withdrawal some people in recovery may benefit frommedication that reestablishes normal brain functiondiminishes cravings or treats coexisting mental healthproblems. medication assisted therapies such as methadone, suboxone or vivitrol may be prescribed. mentalhealth therapy is another possible component in a successful recovery plan

and helps with modifying attitudes andbehaviors related to addiction common approaches include cognitivebehavioral therapy motivational interviewing, couples andfamily counseling and working with a recovery coach. peersupport groups can be an invaluable source of guidance assistance and encouragement forindividuals in recovery as well as for family and friendsimpacted by the addiction twelve-step programs like alcoholicsanonymous and its many offshoots are among thebest known peer support options

their approach doesn't work for everyoneand meetings may be geographically inaccessible so alternatives such as smart recovery,moderation management, secular organizations for sobriety andothers have evolved thanks to social media many of them areonline where they afford the added benefits of being available 24/7 allowing participants to remainanonymous the most important thing is to finda support structure that works best for the person inrecovery. to learn more

about recovery options visit theinformation center at blakerecoverycenter.org or carrierclinic.org

treating addiction

treating addiction

hi i'm doctor hackie reitman, welcome to anotherepisode of exploring different brains, we've got a super all star today dr. bankole johnsonfrom the university of maryland one of the worlds fore most authorities on addictionand so much else about the brain. in fact he is part of the whole brain institutedown there and he's going to tell you about at the university of maryland. bankole welcome. welcome and thanks for having me on your show. well thanks a lot. why don't you introduce yourself to our differentbrains audience bankole.

well my name is professor bankole johnsonand i'm the chairman of the department of psychiatry at the university of maryland. most the chairman in a few other departmentslike neurology and pharmacology, most importantly i help coordinate and direct the activityof the brain consortium unit, which brings all we know about brain science to a collectivetable to provide ourselves with the opportunity to develop these moon shot object that i'mgoing to hopefully radicalize treatments and the way we manage people with brain disorders. you know that is such music to my ears becausehere are different brains we're trying to get it all under one roof and everyone exceptfor you is in all these different silos where

you have mental health issues over here anddevelopmental here and neurological issues here and it's all the same stuff. wouldn't you agree with that? it is all the same stuff and i can give youa perfectly good analogy if you'd like to hear one. i would love it. lets say you were walking down the streetsof else where and unfortunately for you somebody punched you in the head. now you might well say when you got punchedin the head and you later became depressed

because somebody punched me in the head obviouslyit upset me because i wasn't very happy about it and i wasn't happy that i got punched inthe first place. but here is the other piece of it. could it be that when you got punched in theface that caused a swelling in your brain, that swelling in your brain changed specificstructures in your brain and it made you depressed and it had nothing to do with your psychologicalreaction to it which could have been a part but the primary issue is because you got punchedin the head. now also when you get punched in the headas you know, you have traumatic brain injury so you also have traumatic brain injury alsoseeded with it.

so the neurological is associated with thepsychological and is also associated with the behavioral and it's all in one brain. brilliantly put, brilliantly put and i willnot take offence that you were describing some of my 26 pro heavy weight fights wherei took a good beating bankole. i think you won some too. it keeps you humble. now bankole you have no idea, this is suchmusic to my ears it's like a kindred spirit where you get it. now why is it? and i'll quote here steve ronik,he happens to be the head of henderson behavioral

systems down here at behavioral health hendersondown here in florida they have 800 employees, they serve 30,000 patients a year, he saidhackie why is it when you go to a cardiologist or an oncologist there is no stigma but ifyou go to a mental health professional there is a stigma attached and we get better results. we get better results and what you're doingthere, it sounds like it may help get rid of the whole stigma to all of this. i couldn't agree with you more and i thinkit dates back to a few hundred years where people tried to separate the mind from thebody as if it were two components of a system that never really talked about another andat least my angle is going to be some higher

order type of cognitive thinking and the bodywas meant to be basically the mechanics and they were not connected so if you're goingto see someone if you have mental health issue people believe that it must be due to thisnebulas concept of a mind and that its some how your responsibility or at least partiallyyour responsibility and it has nothing to do with your body. well we know now that this is completely incorrect. the brain is the most complex organ in theuniverse, it has connections with you heart, it has connections with basically everythingelse and to give your friend the heart analogy we now know that individuals who have heartdisease often also have mental manifestations

of that heart disease and brain stress ordistress in the brain is also associated with cardiac arrest and cardiovascular disease. it's one system. i think some people like to make it simple,but as my professor used to say it can only be as simple as it really is. that's a naturally segway into the gut brainwhere the gut has more neurons than the brain i think and can really affect the neuroplasticity. you know that has been a fascinating journeyand i would say if you went back 30 years ago and you had talked to people and saidwell what's in your gut can influence what's

in your brain, well that doesn't really makesense because the gut has no direct connections with the brain except for some of its largenerves. the real issue here is we now know that theseneurotransmitters in the brain or these micro bio can provide signals in the brain and certainparts of it. these signals are very important. so maybe we're going to go back to believingwhat we did thousands of years ago, i want people to say well it's my gut feeling. well maybe it might be the best feeling youactually have. maybe its good thinking about and one of thefascinating parts of all of this development

so i can bring back to neuroscience is thatit could be possible in the future for us to be able to understand how these gut organismsprovide signaling in the brain and therefore changing aspects of the gut, either throughdiet or medicines or drugs, that we will be able to influence the affects of the brainwith out having to actually having to get into the brain itself. that would be fascinating. it opens up a whole area of even trying tocreate vaccines in the gut that influence brain inflammation processing and signaling,it's unbelievably exciting. well this is a segway into, lets call themlack of a better term, the traditional approaches

to alcohol addiction and the dr. bankole johnsonapproach. well i hope you don't call it just the dr.bankole johnson approach, i hope you call it the evidence-based approach because i hopeit's evidenced based. there are several myths about alcohol andi usually write about 100 of them when i teach my students, but one of the most importantthings is to realize that alcohol abuse disorder and alcohol dependencies are actually farmore biological disorder, about 60% of what makes you become and alcohol is inherited. therefore, that doesn't mean everybody whohad an alcoholic parent becomes an alcoholic, but it does mean there is a huge susceptibilityfactor.

the other thing that is important to knowis that if you have a biological disease that is altering your genes, altering the way youthink, well maybe it's a good idea to have medicine as well, that also works with someof the psychological components to be able to help treat the disease. another thing i will say is psychologicaltreatments are great, they work, very effective, but medicines work really well as well. andyou have to have both. you can't just simply have psychological treatments. that’s like as you would say fighting inthe ring with one hand tied behind your back. or having one hand by your hip.

it's not really effective treatment, the mosteffective treatment combines medicine and psychological treatment. that's very well said and i often tell peopledon’t buy societies big lie that things are mutually exclusive, you don't just haveto do this or that, combine and take the best of all worlds. i was delighted by the way, my daughter rebecca,who is kind of my hero who is now half way through her masters in applied psychology,the text book she is using right now is biopsychology where they get into the actual anatomy andphysiology explaining different behaviors which may be i don't know, maybe 10 , 20 yearsago you never would have found that in a psychology

class at all. well congratulations to her and congratulationsto the course. i think that one of the sad problems thatwe have is what is currently known is to people who are informed in the field. it can take 10 to 15 years before the averagefamily practitioner or average practitioner gets hold of this information and there foresome people do not get the best treatment. not because they're not going to see theirdoctor but because their doctors are not well informed. this goes to a whole aspect of training.

i want to touch on something really very quicklyif i may. sure it is absolutely important if you have analcohol problem or a substance abuse problem to go and see your doctor because we knowfull well have not usually seen their doctor for a tremendous amount of time and they usuallyhave a multitude of physical problems, blood pressure, diabetes, heart disease, and it'sreally one stop. you go to your doctor to look after your wholehealth whether it's alcohol, your heart disease, your blood pressure, your diabetes, and thedoctor is not meant to compartmentalize one and ignore all the other aspects of your diseases.

it's very well said, and i'm learning of allthese new entities and work from different brains and all our bloggers and just peoplei'm meeting from all over the world, i just learned about something i was completely ignorantof, misphonia, where i've never even heard of it. jennifer jo brout was explaining it to mebecause she suffers from it and i started reading about it. these are people who are not just as you knowsensitive to sound but certain sounds like chewing or breathing drive them into a rage. now you can see on the scans that part ofthe brain and i guess it's probably near the

amygdala light up where it's not just thehypersensitivity it's emotion, it's violence, and they’re ready to go. well you know one of the interesting thingsthat we've learned in neurodiversity is and here is another myth that has come that iwould love to dispel for you. that everybody’s brain is the same, everybody’sbrain is not the same, it's not even close. in fact part of the problem, we all processinformation slightly differently, we may all depending on our genetic makeup, develop signalingpathways and response to different types of sensations and there for everybody’s brainis not the same. that's why the path for meds in the futureis this aspect of personalized medicine because

we finally realize that you can't treat everyonethe same and expect to get the same result and that treatments need to be individualizedand we have very powerful tools at the present time for individualizing medical practice. the question is how long is it going to takeus to educate all doctors to be able to do this. well a segway into artificial intelligence,but that's a story for another date, i suppose my daughter when she became one of nine womenthat year to get her discrete mathematics degree from georgia tech she then wanted totutor people like she always has one on one and i said rebecca why don't you want to teachin a classroom why do you want to tutor and

that led to the quote she told me on the coverof my aspertools book which is "every brain is like a snowflake, no two are alike "andshe gets that and i get that and some of the great scientists of the world being led byyou are starting to get that, everything makes more sense. now the university of maryland where you are,thanks to you in no small part, you've created a vision there, tell us the vision and aboutwhat's going on in the neurosciences at the university of maryland. thank you for that, but first of all i reallydo want to give credit and compliment to a lot of my colleagues.

one of the things that makes me lucky is thati'm surrounded by extremely brilliant people who are part of the brain sciences researchand contortion unit. this brings together a lot of the departmentand it's actually was part of the brain child of dean albert reids, brilliant man, and we'resurrounded by brilliant people, so the work we're doing is a collection of work from ateam. one of the over arching things to go withand go into your artificial intelligence piece, i know you may want to do this for anothertime but it's really important. what we're trying to do is understand, letssay you're a doctor and you go and train and want to treat x disease of the brain.

you can open up a textbook and it says youdiagnose x and you do y and z and you do that for everybody with that disease. we also have a tremendous amount of informationabout what actually happens to individual people. now we never apply that to modify the treatmentwe're giving to the individual. so one of the things we're doing is an artificialintelligence project which we try and assimilate information as well as specific informationand treatments about disease as well as outcomes of similar people to modify the treatment. if you like, if you watched hitchhikers guideto the galaxy, we would have our own marvin

robot, and i hope he won't be depressed walkingaround on the unit providing individualized treatment and he might well be that one personneeds a specific medication for 2 days but you need it for 3 days or 4 days. that kind of learning is only possible onan artificial intelligence platform. a human couldn't do it because there is fartoo much information to put at any one time. that always us to develop even more powerfultreatments. there are very important things in neurosciencei would like to know, for example going back to my analogy of someone getting punched inthe head swelling, you know neuroscience really doesn't understand why some people swellingin the brain comes down really quickly while

for some people it's very slow but we knowit's really linked to outcome. so one of the things we're looking to do withour neuroscience initiative in artificial intelligence is to look at all types of braininjury as if there was brain inflammation. now i say that in a very interesting way becausemost people when you say brain inflammation they think about the brain being inflamedor the brain being diseased and that is just a terrible and a bad thing. the interesting thing is certain types ofneruo inflammation seem to be actually good and protective for the brain and there foreit's very important for us to understand how the brain repairs itself, fixes itself, andunderstands itself.

if we can aid that in terms of insoleco modelsor artificial intelligence we are going to develop some very powerful neuroscience toolsfor the future. well i wish we had more time, i know you havea hard out here shortly and i just wanted you to tell all of our audience whether they'rereading this or watching it or taking in the captions or listening to it as a podcast,how do they get ahold of you and learn more about dr. bankole johnson at the universityof maryland everything you have going on there. well one of the things that person can dois either call or email interesting don't ask about my email address because i probablydon't remember it accurately but it can be supplied, but you can go to the universityof maryland website and you can find us out

and ask questions. also there is also a lot of reading materialthat has emulated from the work that we've been doing that you can actually get accessto and these are free. these are open and these are things that areavailable to the general public especially the works that we've done that are fundedby the national institute of health. but i don't want to go off the show with outcomplimenting you harold because one of the things that you're doing with your neurodiversityprojects is absolutely stupendous, i think it's fascinating and i think bringing informationto the public to help the general public understand the brain, how diverse it is and how theymay be able to address specific problems with

the brain, i think it's absolutely marvelousand kudos to you and your team for doing this. thank you so much for the kind words and iapologize that we weren't able to get to so many things today, we're going to save ourquestions for the next session we get together and thank you so much for being with us. dr. bankole johnson from the university ofmaryland. thank you so much. thank you to you and thank you for your showand thank you to your audience that has been listening and also your viewers.